Enhancement of radiosensitivity by topoisomerase II inhibitor, amrubicin and amrubicinol, in human lung adenocarcinoma A549 cells and kinetics of apoptosis and necrosis induction.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  International Journal of Molecular Medicine

• Publication date

  2006-11-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.3892/IJMM.18.5.909PMID 17016621
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mechanisms of induction of apoptotic DNA fragmentation.

  2009cited by this paper
• Modification of thermosensitivity by amrubicin or amrubicinol in human lung adenocarcinoma A549 cells and the kinetics of apoptosis and necrosis induction.

  2005cited by this paper
• Identification of Differentially Expressed Genes Contributing to Radioresistance in Lung Cancer Cells using Microarray Analysis

  2005cited by this paper
• Additive effects of amrubicin with cisplatin on human lung cancer cell lines.

  2002cited by this paper
• Modification of thermosensitivity and chemosensitivity induced by combined treatments with hyperthermia and adriamycin.

  2001cited by this paper
• Enhancement of heat-induced heat shock protein (hsp)72 accumulation by doxorubicin (Dox) in vitro.

  2000cited by this paper
• p53: death star.

  2000cited by this paper
• Ionizing radiation-induced apoptosis in human lymphoma cell lines differing in p53 status.

  2000cited by this paper
• Critical Evaluation of Techniques to Detect and Measure Cell Death – Study in a Model of UV Radiation of the Leukaemic Cell Line HL60

  1999cited by this paper
• Thermosensitivity, incidence of apoptosis and accumulations of hsp72 and p53 proteins of murine L cells in wild type status of p53 gene.

  1999cited by this paper
• The cellular response to p53: the decision between life and death

  1999cited by this paper
• Novel anticancer drugs in Japan

  1999cited by this paper
• Reactive oxygen species-induced apoptosis and necrosis in bovine corneal endothelial cells.

  1999cited by this paper
• In vivo Efficacy and Tumor‐selective Metabolism of Amrubicin to Its Active Metabolite

  1998cited by this paper
• A New Antitumor Agent Amrubicin Induces Cell Growth Inhibition by Stabilizing Topoisomerase II‐DNA Complex

  1998cited by this paper
• Suppression of heat-induced p53 accumulation and activation by CDDP or x-rays in human glioblastoma cells.

  1998cited by this paper
• Cytotoxicity of Amrubicin, a Novel 9‐Aminoanthracycline, and Its Active Metabolite Amrubicinol on Human Tumor Cells

  1998cited by this paper
• Tumor‐selective Distribution of an Active Metabolite of the 9‐Aminoanthracycline Amrubicin

  1998cited by this paper
• The effects of combined treatments with low hyperthermia and bleomycin on survivals of murine L cells.

  1997cited by this paper
• In vitro effects of hyperthermia combined with cisplatin or peplomycin on the human maxillary carcinoma cell line IMC-2.

  1997cited by this paper
• Hyperthermia, thermotolerance and topoisomerase II inhibitors.

  1995cited by this paper
• Use of fluorescence in situ hybridization to measure chromosome aberrations as a predictor of radiosensitivity in human tumour cells.

  1994cited by this paper
• Function and regulation of ras.

  1993cited by this paper
• p53-mediated cell death: relationship to cell cycle control

  1993cited by this paper
• DNA topoisomerase I and II as targets for rational design of new anticancer drugs.

  1993cited by this paper
• Sensitivity of human cells to mild hyperthermia.

  1993cited by this paper
• Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

  1992cited by this paper
• Effects of exogenous wild-type p53 on a human lung carcinoma cell line with endogenous wild-type p53.

  1992cited by this paper
• Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

  1992cited by this paper
• Structure and function of signal-transducing GTP-binding proteins.

  1991cited by this paper
• Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.

  1991cited by this paper
• p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines.

  1991cited by this paper
• A lack of detectable modification of topoisomerase II activity in a series of human tumor cell lines expressing only low levels of etoposide resistance

  1991cited by this paper
• Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6

  1991cited by this paper
• Polyamine biosynthesis inhibitors combined with systemic hyperthermia in cancer therapy.

  1990cited by this paper
• Antitumor Activities of a Novel 9‐Aminoanthracycline (SM‐5887) against Mouse Experimental Tumors and Human Tumor Xenografts

  1989cited by this paper
• Response of human tumor cell lines in vitro to fractionated irradiation.

  1989cited by this paper
• DNA topoisomerase poisons as antitumor drugs.

  1989cited by this paper
• Relationship between topoisomerase II and radiosensitivity in mouse L5178Y lymphoma strains.

  1989cited by this paper
• Differential patterns of anti‐tumour drug responses and mechanisms of resistance in a series of independently‐derived VP‐16‐resistant human tumour cell lines

  1988cited by this paper
• SV40 DNA replication.

  1988cited by this paper
• Dose-rate effects in normal and malignant cells of human origin.

  1987cited by this paper
• Recent studies of DNA topoisomerases.

  1987cited by this paper
• The morphologic categorization of cell death induced by mild hyperthermia and comparison with death induced by ionizing radiation and cytotoxic drugs.

  1986cited by this paper
• Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene.

  1986cited by this paper
• Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.

  1984cited by this paper
• Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II.

  1984cited by this paper
• Regional chromosomal localization of N-ras, K-ras-1, K-ras-2 and myb oncogenes in human cells.

  1983cited by this paper
• A continuous tumor‐cell line from a human lung carcinoma with properties of type II alveolar epithelial cells

  1976cited by this paper
• In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.

  1973cited by this paper
• Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics

  1972cited by this paper
• Adriamycin (14-hydroxydaunomycin), a novel antitumor antibiotic.

  1969cited by this paper
• The podophyllotoxin-picropodophyllin equilibrium.

  1966cited by this paper
• RADIATION RESPONSE OF MAMMALIAN CELLS GROWN IN CULTURE. V. TEMPERATURE DEPENDENCE OF THE REPAIR OF X-RAY DAMAGE IN SURVIVING CELLS (AEROBIC AND HYPOXIC).

  1965cited by this paper
• X-Ray Damage and Recovery in Mammalian Cells in Culture

  1959cited by this paper

• Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small cell lung cancer.

  2026cites this paper
• Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited‐disease small cell lung cancer: protocol of ACIST study

  2022cites this paper
• Identifying “Many-to-Many” Relationships between Gene-Expression Data and Drug-Response Data via Sparse Binary Matching

  2020cites this paper
• Network-based method for drug target discovery at the isoform level

  2019cites this paper
• Pulmonary Diseases, a Matter of Time

  2017cites this paper
• Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models

  2016cites this paper
• Radiosensitization by the novel DNA intercalating agent vosaroxin

  2012cites this paper
• Effect of miR-34b overexpression on the radiosensitivity of non-small cell lung cancer cell lines.

  2012cites this paper
• Recent Pharmacological Advances: Focus on Small-cell Lung Cancer

  2010cites this paper
• Increase in thiol oxidative stress via glutathione reductase inhibition as a novel approach to enhance cancer sensitivity to X-ray irradiation.

  2009cites this paper
• Thermosensitization by parthenolide in human lung adenocarcinoma A549 cells and p53- and hsp72-independent apoptosis induction via the nuclear factor-kappaB signal pathway.

  2008cites this paper
• Topoisomerase inhibitors as therapeutic weapons

  2007cites this paper